GEN Exclusives

More »

May. 15, Vol. 26, No. 10

    • Point of View

      • Are We Being Outdone by Bacteria?
      • During the late 1960&#8217s, my college roommate suffered a seemingly minor skin infection on a finger, which quickly turned into blood poisoning and resulted in a hip abscess. The infection resolved completely after a few weeks of therapy with ... more »
    • FDA News and Analysis

      • Deviation Controls in Pharmaceutical R&D
      • The title of this article may surprise some who wonder how deviations can occur in an R&D environment and why there should be controls to prevent them. Over the years, various scientists have commented that research is a creative process that re ... more »
    • Feature Articles

      • Inhibiting Protein-Protein Interactions
      • Recombinant therapeutic proteins are a rapidly growing category of the prescription drug market, with sales projected to reach $50 billion worldwide by 2010, according to BCC Research. These products, especially antibodies, tend to be highly specifi ... more »
      • Nonviral Approaches to DNA Delivery
      • Kathy Liszewski
      • Delivering DNA into cells is a rapidly developing area of biotechnology and gene therapy. Additionally, it is a powerful research tool for deciphering gene structure, function, and regulation. Nonviral methods for gene delivery center on the use of ... more »
      • Sample Prep Upstream of Mass Spectrometry
      • Vicki Glaser
      • Continuing advances in MS technology are both driving and aiding progress in the development of novel sample-prep methods. Advances in MS instrumentation are moving toward higher sensitivity, resolution, and throughput, says John Leite, Ph.D., mass ... more »
    • Tutorials

      • Assay: Proteomics Technology for Plasma & Serum
      • Blood is a rich and readily accessible source for the detection of diagnostic markers and therapeutic targets in many human diseases, such as cardiovascular diseases, neurological disorders, and cancer. Currently, however, only a handful of plasma p ... more »
      • Glucose Measurement for Cell Culture
      • Cell cultures have been widely used to express heterogonous genes and produce therapeutic proteins. CHO, HK273, NSO, and Sf9 are some of the most popular cell lines used in cell culture. Glucose is the major carbon source in the cultures. Therefore, ... more »
      • Using Isothermal Titration Calorimetry
      • Enzymes are important in drug discovery and development since they constitute approximately one-half of all known drug targets. Researchers need to understand how enzymes work with natural substrates before they can develop new therapeutic agents. T ... more »
    • Financial Focus

      • Targeting a Multibillion-Dollar Market
      • Querida Anderson
      • Even with its lead drug candidate, AGI-1067, designed to reduce plaque in treating atherosclerosis, still in Phase III, AtheroGenics (AGIX; www.atherogenics.com) is already being touted as an attractive investment for the patient investor. If succes ... more »
    • Corporate Profiles

      • eGene Transforms Genetic Analysis Field
      • While working as an applications scientist in the bio-instrument industry, molecular geneticist Ming Liu, Ph.D., came to appreciate the potential of capillary electrophoresis and decided to develop the technology into a routine tool for the molecula ... more »

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?